openPR Logo
Press release

Respiratory Syncytial Virus Prophylaxis Market to Reach USD 12 Billion by 2034, Growing at a CAGR of 9.5%

12-03-2025 03:00 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Exactitude Consultancy

Respiratory Syncytial Virus Prophylaxis Market

Respiratory Syncytial Virus Prophylaxis Market

Exactitude Consultancy's new report analyzes the Respiratory Syncytial Virus Prophylaxis Market, driven by advancements in monoclonal antibodies, vaccines, and preventive care strategies.

Introduction:
Exactitude Consultancy's latest report on the Respiratory Syncytial Virus Prophylaxis Market forecasts significant growth from USD 5.4 billion in 2024 to USD 12 billion by 2034, growing at a CAGR of 9.5%. The market is driven by increasing awareness, advancements in monoclonal antibody-based prophylaxis, and rising demand for vaccines and preventive treatments.

Download Full PDF Sample Copy of Market Report
https://exactitudeconsultancy.com/request-sample/73648

Key Market Stats & Insights:
• Market Size (2024): USD 5.4 Billion
• Market Size (2034): USD 12 Billion
• CAGR (2025-2034): 9.5%

• Key Segments:
o By Product Type: Monoclonal Antibodies, Vaccines
o By Application: Preventive Care, Treatment
o By End-User: Hospitals, Clinics, Home Care
o By Technology: Recombinant Technology, Virus Vector Technology
o By Distribution Channel: Pharmacies, Online Pharmacies
• Largest Region: North America

Explore Full Report here:
https://exactitudeconsultancy.com/reports/73648/respiratory-syncytial-virus-prophylaxis-market

Market Segmentation:
1. By Product Type: Monoclonal antibodies are leading the market, followed by increasing vaccine production.
2. By Application: Preventive care is the dominant segment, with ongoing efforts to reduce the burden of RSV infections.
3. By Region: North America holds the largest share, driven by significant research funding and high awareness of RSV infections.

Get Your Exclusive Offer with up to 10% Discount
https://exactitudeconsultancy.com/checkout/?currency=USD&type=single_user_license&report_id=73648

Recent Developments in the Market:
• Ongoing developments in monoclonal antibody therapies for RSV are driving market growth.
• Vaccine candidates are undergoing clinical trials, showing promise for broader prophylaxis applications.

Expert Quote:
"The Respiratory Syncytial Virus Prophylaxis Market is experiencing rapid growth as innovative treatments and vaccines are developed to combat the global impact of RSV infections," said Irfan Tamboli, Business Development Executive at Exactitude Consultancy.

Key Drivers and Restraints:
• Drivers: Advances in antibody-based prophylaxis, rising awareness, and increasing healthcare initiatives for at-risk populations.
• Restraints: High treatment costs and regulatory challenges in vaccine approvals.

Market Forecast (2024-2034):
The Respiratory Syncytial Virus Prophylaxis Market is expected to grow at a CAGR of 9.5%, reaching USD 12 billion by 2034, driven by increasing demand for vaccines and monoclonal antibody treatments.

Conclusion:
The Respiratory Syncytial Virus Prophylaxis Market is set for significant growth, offering opportunities for the development of new treatments, vaccines, and preventive strategies to combat RSV infections worldwide.

This report is also available in the following languages : Japanese (呼吸器合胞体ウイルス市場), Korean (呼吸器합회체위르스시장), Chinese (呼吸器합회체위르스시장), French (Marché du virus respiratoire syncytial), German (Markt für das Respiratorische Synzytialvirus), and Italian (Mercato del virus respiratorio sinciziale), etc.

Request for a sample of this research report at (Use Corporate Mail ID for Quick Response) @
https://exactitudeconsultancy.com/request-sample/73648

Our More Reports:

TCR Therapy Market
https://exactitudeconsultancy.com/reports/72878/tcr-therapy-market

Niemann-Pick Disease Market
https://exactitudeconsultancy.com/reports/72880/niemann-pick-disease-market

Biologics Contract Research Organization Market
https://exactitudeconsultancy.com/reports/72882/biologics-contract-research-organization-market

Hypertrophic Cardiomyopathy Market
https://exactitudeconsultancy.com/reports/72884/hypertrophic-cardiomyopathy-market

https://bulletin.exactitudeconsultancy.com/

https://www.thehealthanalytics.com/

https://www.analytica.global/

https://www.marketintelligencedata.com/

https://www.marketinsightsreports.com/

Connect Us:
Irfan Tamboli
PHONE NUMBER +1 (704) 266-3234
EMAIL ADDRESS: sales@exactitudeconsultancy.com

About Us
Exactitude Consultancy is a market research & consulting services firm which helps its client to address their most pressing strategic and business challenges. Our market research helps clients to address critical business challenges and also helps make optimized business decisions with our fact-based research insights, market intelligence, and accurate data.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Respiratory Syncytial Virus Prophylaxis Market to Reach USD 12 Billion by 2034, Growing at a CAGR of 9.5% here

News-ID: 4299099 • Views:

More Releases from Exactitude Consultancy

Erythropoietic Protoporphyria Market to Reach USD 1.05 Billion by 2034, Growing at a CAGR of 5.3%
Erythropoietic Protoporphyria Market to Reach USD 1.05 Billion by 2034, Growing …
Exactitude Consultancy's new report explores the growing Erythropoietic Protoporphyria Market, driven by advancements in therapeutic treatments and increased disease awareness. Introduction: Exactitude Consultancy's latest report on the Erythropoietic Protoporphyria Market forecasts strong growth from USD 620 million in 2024 to USD 1.05 billion by 2034, growing at a CAGR of 5.3%. The market is driven by rising awareness of the disorder, advancements in pharmacological treatments, and the development of new therapies. Download Full
mRNA Synthesis and Manufacturing Market to Reach USD 18.2 Billion by 2034, Growing at a CAGR of 11.1%
mRNA Synthesis and Manufacturing Market to Reach USD 18.2 Billion by 2034, Growi …
Exactitude Consultancy's new report highlights the growth of the mRNA Synthesis and Manufacturing Market, driven by increased vaccine production, advancements in mRNA technologies, and global healthcare needs. Introduction: Exactitude Consultancy's latest report on the mRNA Synthesis and Manufacturing Market forecasts substantial growth from USD 6.5 billion in 2024 to USD 18.2 billion by 2034, growing at a CAGR of 11.1%. This growth is fueled by the increasing demand for mRNA-based vaccines, advancements
Peanut Hypersensitivity Market to Reach USD 4.5 Billion by 2034, Growing at a CAGR of 8.1%
Peanut Hypersensitivity Market to Reach USD 4.5 Billion by 2034, Growing at a CA …
Exactitude Consultancy's new report examines the Peanut Hypersensitivity Market, driven by advancements in immunotherapies, diagnostics, and growing awareness of food allergies. Introduction: Exactitude Consultancy's latest report on the Peanut Hypersensitivity Market forecasts growth from USD 2.1 billion in 2024 to USD 4.5 billion by 2034, growing at a CAGR of 8.1%. The market is driven by increased awareness, advancements in immunotherapies, and new diagnostic methods for peanut allergies. Download Full PDF Sample Copy
Herceptin Biosimilars Market to Reach USD 12 Billion by 2034, Growing at a CAGR of 15%
Herceptin Biosimilars Market to Reach USD 12 Billion by 2034, Growing at a CAGR …
Exactitude Consultancy's new report delves into the growing Herceptin Biosimilars Market, driven by advancements in oncology treatments and the increasing adoption of biosimilars. Introduction: Exactitude Consultancy's latest market research report on the Herceptin Biosimilars Market forecasts significant growth from USD 3.2 billion in 2024 to USD 12 billion by 2034, growing at a CAGR of 15%. This growth is attributed to the increasing adoption of Herceptin biosimilars in breast cancer treatments, affordability

All 5 Releases


More Releases for Virus

Zika Virus Vaccines Market 2022 | High rate of incidence of active Zika virus in …
Zika Virus Vaccines Market Report, published by Allied Market Research, forecasts that the global market is expected to garner $18,697 million by 2022, registering a CAGR of 5.2% during the forecast period 2017-2022.Key opportunities include the need for vaccines for immunization & prevention of further spread of Zika virus infection and for treatment of Zika-linked birth defects. Do Enquiry for Sample Report @ https://www.alliedmarketresearch.com/request-sample/1817 The outbreak of Zika virus infection in Latin
Viral Disease Diagnosis Market - Revolutionary Trends 2025 | Cytomegalovirus, De …
Global Viral Disease Diagnosis Market: Snapshot Thousands of deaths are occurring on a yearly basis on account of various viral infectious diseases. Some of the viral diseases occurring are rabies, avian influenza, HIV-1, measles, enterovirus, poliovirus, coronavirus, and Metapneumovirus. This has resulted in global public health concerns. Common influenza, contagious infections, and serious pandemics are some of the issues that need clinical prognosis for an early detection of the infectious agent.
Viral Disease Diagnosis Market to See Huge Growth by 2025 | Measles Virus, Polio …
Global Viral Disease Diagnosis Market: Snapshot Thousands of deaths are occurring on a yearly basis on account of various viral infectious diseases. Some of the viral diseases occurring are rabies, avian influenza, HIV-1, measles, enterovirus, poliovirus, coronavirus, and Metapneumovirus. This has resulted in global public health concerns. Common influenza, contagious infections, and serious pandemics are some of the issues that need clinical prognosis for an early detection of the infectious agent.
Virus Free Corporate Training
Interaction for learning is critical but our customers are slowly starting to realise that this doesn’t necessarily need to take place face to face. Virtual instructor led training (VILT) makes learning more accessible by removing geographical barriers. It helps improve user product adoption, knowledge and career development and eliminates the need for costly and time-consuming travel. Still, there’s often a misconception that in person training is the only type of
Tick-borne Encephalitis Inactivated Vaccine Market Report 2018: Segmentation by …
Global Tick-borne Encephalitis Inactivated Vaccine market research report provides company profile for Pfizer Inc., Encephalitis Global, Inc., The Cochrane Collaboration, Sonic HealthPlus Pty Ltd., Superdrug Health Clinic, GlaxoSmithKline plc, Merck & Co., Inc., Baxter International Inc., London Travel Clinic and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of
Oncolytic Virus Therapy Market Oncolytic Virus Therapy Clinical Pipeline Report …
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents Prologue to Oncolytic Virus 1.1 Outline of Oncolytic Virotherapy 1.2 Trail from Genesis to Biogenetics Primer of Virotherapy in Malignancies 2.1 Oncolytic Viruses towards Cancer 2.2 Approaches for Targeting Tumor Cells 2.2.1 Pro Apoptotic Targeting 2.2.2 Translational Targeting 2.2.3 Transcriptional Targeting 2.2.4 Transductional Targeting Mechanism